Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17:251–67.
Article PubMed PubMed Central Google Scholar
Okubo M, Noguchi S, Awaya T, Hosokawa M, Tsukui N, Ogawa M, et al. RNA-seq analysis, targeted long-read sequencing and in silico prediction to unravel pathogenic intronic events and complicated splicing abnormalities in dystrophinopathy. Hum Genet. 2023;142:59–71.
Article PubMed CAS Google Scholar
Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Prim. 2021;7:13.
Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, et al. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat. 2015;36:395–402.
Article PubMed CAS Google Scholar
Jones HF, Bryen SJ, Waddell LB, Bournazos A, Davis M, Farrar MA, et al. Importance of muscle biopsy to establish pathogenicity of DMD missense and splice variants. Neuromuscul Disord. 2019;29:913–9.
Zhao L, Hu C, Pan S, Wang D, Wang Y, Li X. Two novel deep intronic variants cause Duchenne muscular dystrophy by splice-altering mechanism. Neuromuscul Disord. 2024;45:104470.
Chen Y, Xi J, Zhu W, Lin J, Luo S, Yue D, et al. GNE myopathy in Chinese population: hotspot and novel mutations. J Hum Genet. 2019;64:11–16.
Article PubMed CAS Google Scholar
Gurvich OL, Tuohy TM, Howard MT, Finkel RS, Medne L, Anderson CB, et al. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Ann Neurol. 2008;63:81–9.
Article PubMed CAS Google Scholar
Jiao K, Zhang J, Wang N, Gu X, Chang X, Xia X, et al. Human induced pluripotent stem cell line (FDHSi005-A) derived from a patient with a deep intronic variant in the GNE gene. Stem Cell Res. 2024;81:103562.
Article PubMed CAS Google Scholar
Abujarour R, Bennett M, Valamehr B, Lee TT, Robinson M, Robbins D, et al. Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery. Stem Cells Transl Med. 2014;3:149–60.
Article PubMed PubMed Central CAS Google Scholar
Laberthonnière C, Novoa-Del-Toro EM, Delourme M, Chevalier R, Broucqsault N, Mazaleyrat K, et al. Facioscapulohumeral dystrophy weakened sarcomeric contractility is mimicked in induced pluripotent stem cells-derived innervated muscle fibres. J Cachexia Sarcopenia Muscle. 2022;13:621–35.
Xie Z, Sun C, Liu C, Xie Z, Wei L, Yu J, et al. Clinical, muscle imaging, and genetic characteristics of dystrophinopathies with deep-intronic DMD variants. J Neurol. 2023;270:925–37.
Article PubMed CAS Google Scholar
Tuffery-Giraud S, Saquet C, Chambert S, Claustres M. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy. Hum Mutat. 2003;21:608–14.
Article PubMed CAS Google Scholar
Gorgoglione D, Sabbatini D, Riguzzi P, Capece G, Pane M, Servidei S, et al. Natural history of Becker muscular dystrophy: DMD gene mutations predict clinical severity. Brain. 2025;148:1695–706.
Xiao, R, Zhou M., Wang P., Zeng B., Wu L., Hu Z., et al. Full-length dystrophin restoration via targeted exon addition in DMD-patient specific iPSCs and cardiomyocytes. Int J Mol Sci. 2022;23:9176.
Zhu S, Law A, Deng R, Poon E, Lo CW, Kwong A, et al. Generation of genomic-integration-free human induced pluripotent stem cells and the derived cardiomyocytes of X-linked dilated cardiomyopathy from DMD gene mutation. Stem Cell Res. 2020;49:102040.
Article PubMed CAS Google Scholar
Tang F, Xiao Y, Zhou C, Zhang H, Wang J, Zeng Y. NGS-based targeted sequencing identified six novel variants in patients with Duchenne/Becker muscular dystrophy from southwestern China. BMC Med Genom. 2023;16:121.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Article PubMed PubMed Central Google Scholar
Chang ACY, Pardon G, Chang A, Wu H, Ong SG, Eguchi A, et al. Increased tissue stiffness triggers contractile dysfunction and telomere shortening in dystrophic cardiomyocytes. Stem Cell Rep. 2021;16:2169–81.
Comments (0)